Liquidia Corporation (LQDA) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Morrisville, NC, 미국. 현재 CEO는 Roger A. Jeffs.
LQDA 을(를) 보유 IPO 날짜 2018-07-26, 170 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $3.41B.
Liquidia Corporation is a biopharmaceutical company founded in 2004 and headquartered in Morrisville, North Carolina, focused on developing and commercializing innovative treatments for unmet patient needs in the United States. The company's lead product candidate, YUTREPIA, is an inhaled dry powder formulation of treprostinil designed to treat pulmonary arterial hypertension. In addition to its proprietary pipeline, Liquidia manufactures and distributes generic treprostinil injection throughout the U.S. market, combining both innovative drug development and generic pharmaceutical distribution capabilities.
